Jean Van Nuwenborg, Ph.D., MBA, combines a scientific and business background. Following a career start as a strategy consultant with Bain & Company and as a CEO of a young company, Jean has been active as a Venture Capital and Private Equity partner for over a decade at Theodorus, specialized in Biotech and Med-Science spin-offs.
He accompanied numerous capital increases and has held director positions at Bone Therapeutics and Ovizio Imaging Systems.
He holds a Ph.D. in Pharmaceutical Sciences and an MBA from Vlerick Business School.
Qbic is a seed and early-stage and sector agnostic inter-university fund investing in spin-offs and young innovating companies that have a technology link with Qbic’s partner universities and research institutions. Qbic is managed by an independent team of seasoned investment and business professionals.